Tag: medical cannabis

FSD Pharma Inc. Announces $7.5 Million Dollar at $1 Per Share Investment as Part of Existing Strategic Alliance with Auxly Cannabis Group Inc.

MotherlodeTV
C.HUGE, FSD Pharma, cannabis, pot

FSD Pharma Inc. (“FSD” or the “Company”) (CSE:HUGE) is pleased to announce that pursuant to the approved construction and development budget announced on July 3, 2018 (Link), Auxly Cannabis Group Inc. (TSX.V – XLY) (“Auxly”) has made an equity investment into the Company at $1.00 per Class B Subordinate Voting Share for total proceeds of $7.5 million. No fees were paid to brokers in connection with the transaction. read more

FSD Pharma Announces Upgraded Listing to OTCQB Venture Market

MotherlodeTV
C.HUGE, FSD Pharma, cannabis, pot
Cision

FSD Pharma Inc. (“FSD Pharma” or the “Company”) (CSE: HUGE) (FRA: 0K9) announced today that its subordinate voting shares have been upgraded to a listing on the OTCQB (“OTCQB”) Venture Market, trading under the ticker symbol “FSDDF.” The Company’s subordinate voting shares continue to be listed on the Canadian Stock Exchange (“CSE”) under the ticker symbol “HUGE” and on the Frankfurt Stock Exchange (“FRA”) under the ticker symbol “0K9.” read more

FSD Pharma signs collaboration and profit sharing agreement with Canntab for production and market of oral dose delivery platforms

MotherlodeTV
C.HUGE, FSD Pharma, cannabis, pot
Cision

FSD Pharma Inc. (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company), which, through its wholly-owned subsidiary FV Pharma Inc., is a licensed producer pursuant to the Access to Cannabis for Medical Purposes Regulations, is pleased to announce that it has signed a definitive collaboration and profit sharing agreement (the “Agreement“) with Canntab Therapeutics Limited (CSE:PILL) (“Canntab“), a leader in the rapidly growing cannabis pill market, effective September 17, 2018. Under the terms of the Agreement, FSD Pharma will assist Canntab to obtain a license to process and sell cannabis products pursuant to the Cannabis Act (the “License“), and will provide Canntab with space at its facility (the “FSD Facility“), which is located just one hour east of Toronto in Cobourg, Ontario (the “Transaction“). read more

FSD Pharma joins Snipp’s Cannabis Marketing Resource Center

MotherlodeTV
C.HUGE, FSD Pharma, cannabis, pot
Cision

FSD Pharma Inc. (“FSD” or the “Company”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) today announced that it has joined the Cannabis Marketing Resource Center (“CMRC”) provided by Snipp Interactive Inc. (“Snipp”) (OTCQB: SNIPF; TSX-V: SPN), a global provider of digital marketing promotions, rebates and loyalty solutions. FSD has now joined some of the largest licensed producers in Canada that currently use the CMRC and the technology solutions provided by Snipp.  read more

FSD Pharma to Expand into Jamaican Market and Introduce FSD Jamaica

MotherlodeTV
C.HUGE, FSD Pharma, cannabis, pot
Cision

FSD Pharma Inc. (“FSD” or the “Company”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) is pleased to announce that it intends to launch a strategic partnership into the Jamaican cannabis market as part of its plan to expand internationally. FSD has signed a Letter of Intent (“LOI”) effective September 10, 2018 with JJAMACANN Inc. (“JJAMACANN”) to form a joint venture operating as FSD Jamaica (“FSD Jamaica”). FSD Jamaica expects to partner locally with Nature’s Purest Limited (“NPL”), a Jamaican corporation with a cultivation license and existing operations in Jamaica. read more

FSD Pharma Breaks All-time Daily Volume Record and Continues to Make History

MotherlodeTV
C.HUGE, FSD Pharma, cannabis, pot
Cision

FSD Pharma Inc. (“FSD” or the “Company”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9), is pleased to report that on September 11, 2018 the Company traded an aggregate total of exactly 213,761,823 shares. FSD traded 143,260,988 Class B subordinate voting shares on the Canadian Securities Exchange (“CSE”), 1,888,500 on AQC-Lit, 15,369,000 on AQC-Neo, 241,740 on CXC, 5,309,399 on CX2, 6,473,592 on CXD, 22,500 on Lynx, 24,750,500 on Omega and 16,445,604 on MatchNow. This is the largest total quantity of share volume traded by a CSE listed issuer by over 15.7% above the recorded all-time high of 184,718,114 also achieved by FSD on September 10, 2018, as confirmed by the CSE. This record is also  41% over the Company’s previous reporting of achieving an all-time high of 151,183,895 on September 4, 2018. read more

FSD Pharma Issues 40,000,000 Stock Options to Director Dr. Raza Bokhari Conditional on NASDAQ listing

MotherlodeTV
C.HUGE, FSD Pharma, cannabis, pot
Cision

FSD Pharma Inc. (“FSD Pharma” or the “Company”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) announces that pursuant to its Stock Option Plan, the Board approved the grant of 3,000,000 stock options for class B subordinate voting shares of the Company (the “Options“) on August 14, 2018 to Dr. Raza Bokhari following his appointment as a Director. The Options vest immediately and are exercisable at a price of $0.13 for a period of five years. The Company has also cancelled 15,000,000 stock options that had been previously issued at $0.05.  read more

FSD Pharma Congratulates High Tide Ventures for Selection as Supplier to Ontario Cannabis Retail Corporation

MotherlodeTV
C.HUGE, FSD Pharma, cannabis, pot
Cision

FSD Pharma Inc. (“FSD Pharma” or “FSD”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) today congratulated High Tide Ventures Inc. (“High Tide”) for the selection of its wholly-owned subsidiary Famous Brandz Inc. (“Famous Brandz”) as an accessories supplier to the Ontario Cannabis Retail Corporation, operating as the Ontario Cannabis Store (“OCS”). Under the announcement by the OCS on September 5, 2018, Famous Brandz was one of ten accessories suppliers newly-selected to supply accessories to the adult-use market in the Province of Ontario. read more

FSD Pharma breaks all-time daily volume record and makes history again

MotherlodeTV
C.HUGE, FSD Pharma, cannabis, pot
Cision

FSD Pharma Inc. (“FSD” or the “Company”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9), is pleased to report that on September 4, 2018 the Company traded an aggregate total of exactly 151,183,895 shares. FSD traded 106,397,927 Class B subordinate voting shares on the Canadian Securities Exchange (“CSE”), 5,883,500 on AQC-Lit, 5,180,500 on AQC-Neo, 501,526 on CXC, 751,300 on CX2, 8,781,217 on CXD, 382,000 on Lynx, 8,631,000 on Omega and 14,674,925 on MatchNow. This is the largest total quantity of share volume traded by a CSE listed issuer by over 33.6% above the recorded all-time high of 113,135,861 achieved by FSD on its first day of trading, as confirmed by the CSE. read more